Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

abacavir 300 MG Oral Tablet

Known as: ABACAVIR SO4 300MG TAB,UD, ABACAVIR SULFATE 300 ORAL TABLET, ABACAVIR SULFATE 300 mg ORAL TABLET, FILM COATED [Abacavir] 
 
National Institutes of Health

Related topics

Related topics

26 relations
Acquired Immunodeficiency SyndromeCroscarmellose SodiumDrug AllergyHIV Infections
Expand

Broader (2)

Antiviral Agentsabacavir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection.
BACKGROUND Long-acting injectable regimens may simplify therapy for patients with human immunodeficiency virus type 1 (HIV-1… Expand
Is this relevant?
2019
2019
Development of Long-acting Nanoformulated Abacavir ProTides
 
Is this relevant?
2017
2017
A humanized mouse model for HIV-2 infection and efficacy testing of a single-pill triple-drug combination anti-retroviral therapy.
While HIV-2 is a causative agent for AIDS in addition to the better studied HIV-1, there is currently no suitable animal model… Expand
Is this relevant?
2016
2016
Development and characterization of a long-acting nanoformulated abacavir prodrug.
AIM A myristoylated abacavir (ABC) prodrug was synthesized to extend drug half-life and bioavailability. METHODS Myristoylated… Expand
Is this relevant?
2015
2015
HLA-assoziierte Arzneimittelunverträglichkeit
Unerwunschte Arzneimittelwirkungen (UAW) stellen ein groses Problem im Gesundheitssystem dar, denn sie werden haufig unterschatzt… Expand
Is this relevant?
Review
2015
Review
2015
Drug Induced Steatohepatitis: An Uncommon Culprit of a Common Disease
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed countries. Its frequency is increasing… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Toward eradicating HIV reservoirs in the brain: inhibiting P-glycoprotein at the blood-brain barrier with prodrug abacavir dimers.
Eradication of HIV reservoirs in the brain necessitates penetration of antiviral agents across the blood-brain barrier (BBB), a… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Application of phosphoramidate pronucleotide technology to abacavir leads to a significant enhancement of antiviral potency.
We report the first application of pronucleotide (ProTide) technology to the antiviral agent abacavir (Ziagen), used for the… Expand
Is this relevant?
2004
2004
4'-substituted carbovir- abacavir and derivatives and analogues thereof, with HIV and HCV antiviral activity
 
Is this relevant?
1998
1998
Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV‐infected adults
Objectives:To evaluate, over 12 weeks, the antiretroviral activity and safety of abacavir, used alone and in combination with… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE